Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Stopping Tumor Growth During Hypoxia
Disease Discoveries

Stopping Tumor Growth During Hypoxia

By Nora DunneOct 3, 2014
Share
Facebook Twitter Email
Arrows point to tumor lesions in a stained lung section. Silencing HOIL-1L decreased lung tumors.

Northwestern Medicine scientists have found a new way to suppress tumor growth during hypoxia, a common characteristic of many rapidly forming lung and glioblastoma brain cancers.

Hypoxia – when tissues in the body are not supplied enough oxygen – develops in the central regions of fast-growing solid tumors. The cells there adapt to this stress and actually become stronger, increasing tumor progression and resistance to therapies such as radiation and chemotherapy.

“We wanted to know why cells exposed to hypoxia survive and even thrive in such an environment,” said Jacob Sznajder, MD, chief of Medicine-Pulmonary and Ernest S. Bazley Professor of Medicine. “We found that during the hypoxic stress, cells activate complex mechanisms of adaptation and survival.”

Dr. Sznajder and his team focused on PKCζ, a protein kinase shown in previous studies to suppress tumor growth. For that reason, it’s a possible target in anticancer therapies. When PKCζ decreases, cancer cells survive and tumors grow. In this study, published in the American Journal of Respiratory and Critical Care Medicine, the scientists investigated the mechanism that causes PKCζ to stop working during hypoxia.

Jacob Sznajder, MD, chief of Medicine-Pulmonary and Ernest S. Bazley Professor of Medicine, was the senior author of the study.

They discovered this mechanism in a ubiquitin ligase, a type of molecule that inactivates proteins like PKCζ. Specifically, they identified HOIL-1L, a ubiquitin ligase that is highly expressed in patients with lung cancers and specifically triggers degradation of PKCζ. The study found that inhibiting HOIL-1L stops that PKCζ degradation and, likewise, tumor growth.

The group tested the finding in vitro and in vivo. Importantly, they saw high levels of HOIL-1L and low levels of PKCζ in tissues from patients with lung cancer tumors.

“Broadly, this previously unrecognized mechanism is important for understanding cancerous cell growth,” said Dr. Sznajder. “It’s amenable to manipulation and therapy against cancer.”

This study was supported by National Institutes of Health (NIH) grants PO1 HL-071643 and HL-48129; the German Research Foundation; the Northwestern University Flow Cytometry Facility, Cell Imaging Facility and Mouse Histology and Phenotyping Laboratory; and Cancer Center Support Grant NCI CA060553.

Cancer Patient Care Pulmonology Research
Share. Facebook Twitter Email

Related Posts

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023

Comments are closed.

Latest News

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
_5NM1245
230204_SERIO_MANDELL_Feinberg_Formal_0928
_5NM1715
_5NM0526
_5NM1026 (1)
_5NM1906
_5NM2173
230204_SERIO_MANDELL_Feinberg_Formal_0896
230204_SERIO_MANDELL_Feinberg_Formal_1113
230204_SERIO_MANDELL_Feinberg_Formal_1868
230204_SERIO_MANDELL_Feinberg_Formal_1237
230204_SERIO_MANDELL_Feinberg_Formal_1172

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.